Bronchiectasis and drugs of ingredients of diclofenac sodium (a real world drug study)


Summary:

Bronchiectasis is found among people who take drugs with ingredients of diclofenac sodium, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 143,288 people who have side effects when taking drugs with ingredients of diclofenac sodium from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Diclofenac sodium, Dyloject, Pennsaid, Solaraze, Voltaren, Voltaren arthritis pain, Voltaren-xr.


On Jun, 09, 2026

143,288 people reported to have side effects when taking drugs with ingredients of diclofenac sodium.
Among them, 49 people (0.03%) have Bronchiectasis


What is Bronchiectasis?

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 785 drugs and 857 conditions by eHealthMe. Check the latest studies of Bronchiectasis.

Number of reports submitted per year:

Could drugs with ingredients of diclofenac sodium cause Bronchiectasis?

Time on drugs with ingredients of diclofenac sodium when people have Bronchiectasis *:

  • < 1 month: 88.89 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 11.11 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bronchiectasis when taking drugs with ingredients of diclofenac sodium *:

  • female: 77.55 %
  • male: 22.45 %

Age of people who have Bronchiectasis when taking drugs with ingredients of diclofenac sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.0 %
  • 40-49: 7.5 %
  • 50-59: 10.0 %
  • 60+: 77.5 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 25 people, 51.02%
  2. Dyslipidaemia (abnormal amount of lipids): 7 people, 14.29%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 12.24%
  4. High Blood Pressure: 4 people, 8.16%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.12%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 6.12%
  7. Osteoporosis (bones weak and more likely to break): 2 people, 4.08%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.08%
  9. Dyspnea (difficult or laboured breathing): 2 people, 4.08%
  10. Depression: 2 people, 4.08%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Methotrexate: 9 people, 18.37%
  2. Zydelig: 6 people, 12.24%
  3. Vitamin D3: 6 people, 12.24%
  4. Pegasys: 6 people, 12.24%
  5. Theo-Dur: 6 people, 12.24%
  6. Valtrex: 6 people, 12.24%
  7. Norvasc: 6 people, 12.24%
  8. Advair Hfa: 5 people, 10.20%
  9. Enbrel: 5 people, 10.20%
  10. Folic Acid: 5 people, 10.20%

Other side effects people have besides Bronchiectasis *:

You may use this to check any potential undetected side effects.

  1. Dyspnea (difficult or laboured breathing): 15 people, 30.61%
  2. Cough: 14 people, 28.57%
  3. Fatigue (feeling of tiredness): 13 people, 26.53%
  4. Pneumonia: 12 people, 24.49%
  5. Weakness: 9 people, 18.37%
  6. Rales (an abnormal respiratory sound characterized by fine crackles): 9 people, 18.37%
  7. Idiopathic Pulmonary Fibrosis (chronic lung disease): 9 people, 18.37%
  8. Interstitial Lung Disease: 7 people, 14.29%
  9. Tinnitus (a ringing in the ears): 7 people, 14.29%
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 10.20%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of diclofenac sodium, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: